Merck (MRK) Income from Continuing Operations (2009 - 2026)

Merck has disclosed Income from Continuing Operations across 18 years of filings, most recently posting 4209000000.0 for Q1 2026.

• In Q1 2026, Income from Continuing Operations fell 182.77% year-over-year to 4209000000.0; the TTM figure through Mar 2026 stood at 8968000000.0 (down 48.61% YoY), while the FY2025 annual figure was 18263000000.0, up 6.6% from the prior year.
• Income from Continuing Operations declined to 4209000000.0 in Q1 2026, from 2962000000.0 in the prior quarter.
• Over the last five years, Income from Continuing Operations for MRK reached as high as 5787000000.0 in Q3 2025 and fell as low as 5937000000.0 in Q2 2023.
• The 5-year median for Income from Continuing Operations is 3744000000.0 (2024), against an average of 2713235294.12.
• Annual changes were most pronounced in 2023 — Income from Continuing Operations plunged 250.34% — and 2024, when it soared 405.38%.
• A 5-year view of Income from Continuing Operations shows it stood at 3018000000.0 in 2022, then plunged by 140.62% to 1226000000.0 in 2023, then soared by 405.38% to 3744000000.0 in 2024, then decreased by 20.89% to 2962000000.0 in 2025, then slumped by 242.1% to 4209000000.0 in 2026.
• According to Business Quant data, Income from Continuing Operations over the past three periods registered 4209000000.0, 2962000000.0, and 5787000000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.